<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Lucida Grande";}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:18.0pt;
	margin-left:0cm;
	font-size:14.0pt;
	font-family:"Arial","sans-serif";}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:9.0pt;
	margin-left:0cm;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-weight:normal;
	font-style:italic;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	font-size:9.0pt;
	font-family:"Lucida Grande","sans-serif";}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:36.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Lucida Grande","sans-serif";}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Arial","sans-serif";}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri","sans-serif";
	color:#365F91;
	font-style:italic;}
span.UnresolvedMention
	{mso-style-name:"Unresolved Mention";
	color:#605E5C;
	background:#E1DFDD;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	font-family:"Arial","sans-serif";}
span.Bodytext2
	{mso-style-name:"Body text \(2\)_";
	font-variant:normal !important;
	letter-spacing:0pt;
	font-weight:normal;
	font-style:normal;
	text-decoration:none none;}
span.Bodytext20
	{mso-style-name:"Body text \(2\)";
	font-family:"Microsoft Sans Serif","sans-serif";
	font-variant:normal !important;
	color:black;
	position:relative;
	top:0pt;
	letter-spacing:0pt;
	font-weight:normal;
	font-style:normal;
	text-decoration:underline none underline;}
.MsoChpDefault
	{font-size:10.0pt;
	font-family:"Tahoma","sans-serif";}
 /* Page Definitions */
 @page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-GB link=blue vlink=purple>

<div class=WordSection1>

<h2><span style='font-size:14.0pt'>COVID-19 Palliative Care </span></h2>

<h2><i>Executive summary</i></h2>

<h2>Introduction</h2>

<p class=MsoNormal>Palliative care is defined as the prevention and relief of
suffering of patients facing a life-threatening illness (including those who
may recover). It enhances quality of life, promotes dignity and comfort and may
also positively influence the course of illness. </p>

<p class=MsoNormal>Palliative care is not only started when all active care is
stopped but rather it is applicable early in the course of illness in
conjunction with other therapies intended to prolong life. It should be
integrated with prevention, early diagnosis and treatment of serious or
life-limiting health problems at all levels of any health system. </p>

<p class=MsoNormal>There is currently no cure for COVID-19 and patients may
well present very unwell with rapid deteriorations. As such, you will never be
wrong to consider patients with a palliative approach of managing symptoms and
making them as comfortable as possible whether it is for the last hours of
life, the last days or, in fact, until they make a recovery.</p>

<p class=MsoNormal>WHO state that “Humanitarian responses to emergencies and
crises should include palliative care and symptom control. Responses that do
not include palliative care are medically deficient and ethically
indefensible.” </p>

<h2>Target users</h2>

<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Doctors</p>

<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Nurses</p>

<h2>Target area of use </h2>

<p class=MsoListParagraph style='text-indent:-18.0pt'><span style='font-family:
Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Ward</p>

<h2>Key areas of focus / New additions / Changes </h2>

<p class=MsoNormal>This guideline provides an assessment tool and guidance on
symptom management. Also addresses fluids and nutrition at the end of life,
patient-centred care and paediatric issues. </p>

<h2>Limitations</h2>

<p class=MsoNormal>The Clinical Service Department may have to adapt depending
on what stage of the pandemic we are in as well as staffing levels. Some
interventions will depend on adequate staffing levels and some drugs may become
unavailable at times.</p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>

<h2>Assessment Tool</h2>

<p class=MsoNormal><span lang=EN-US>The first stage of palliative care will
always be a detailed and thorough assessment. Below are the key areas to
address with each patient on a daily basis. </span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Symptoms &amp; Side-effects</span></b></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Is the patient experiencing:</span></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Breathlessness</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Cough</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Delirium or agitation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Fever</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Nausea</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Pain</span></p>
  <p class=MsoNormal><span lang=EN-US>Are any of the medications prescribed
  likely to cause side effects? If so, pre-empt these and write some PRN
  medications. For example, morphine will cause nausea and constipation, so
  prescribe metoclopramide and bisacodyl.</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Food &amp; Fluids</span></b></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Is patient eating and drinking? Do they
  require nutrition or fluids? If they are very unstable then should feeds stop
  and be under review?</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Bowels &amp; bladder</span></b></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Is the patient passing urine and opening
  bowels without difficulty? Do they require a catheter for comfort as they are
  unable to mobilise to the toilet or use a commode?</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Psychological &amp; Social</span></b></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>How is the patient’s mood? Is there
  anything you can do to support them?</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Tube review </span></b></p>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>What tubes (e.g. NG, catheter, cannula)
  are in situ, are they all functioning well and are they all still necessary?</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top style='width:120.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Mobility</span></b></p>
  </td>
  <td width=415 valign=top style='width:311.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Can the patient mobilise or change
  position independently. Are there are pressure sores?</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<b><span lang=EN-US style='font-size:12.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></b>

<h2><span lang=EN-US>&nbsp;</span></h2>

<h2><span lang=EN-US>Symptom Control</span></h2>

<h3><span lang=EN-US>Breathlessness</span></h3>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:58.45pt'>
  <td width=225 valign=top style='width:168.45pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:58.45pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Positioning – sat up</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Relaxation techniques</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Cool cloth for the face</span></p>
  </td>
 </tr>
</table>

<h3><span lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></h3>

<div align=right>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:228.75pt'>
  <td width=353 valign=top style='width:264.65pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:228.75pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pharmacological Measures</span></b></p>
  <p class=MsoNormal><i><span lang=EN-US>Opioids for relieving breathlessness:</span></i></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Morphine Sulphate Tablets 7.5 mg BD (titrate
  to maximum 30 mg BD noting that tablets are 15 mg each, can be cut into
  quarters and must always be BD as modified release). </span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral morphine sulphate solution 2.5-5&nbsp;mg
  PRN</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>SC morphine 1-2 mg PRN</span></p>
  <p class=MsoNormal><i><span lang=EN-US>Distress caused by breathlessness</span></i></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>SC Midazolam 2.5-5 mg PRN</span></p>
  <p class=MsoNormal><i><span lang=EN-US>Severe breathlessness, not expected to
  survive</span></i></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>SC morphine 5-10 mg PRN 2 hourly</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>SC midazolam 5-10 mg PRN 1-4 hourly</span></p>
  </td>
 </tr>
</table>

</div>

<h3><span lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></h3>

<h3><span lang=EN-US>Cough</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:93.1pt'>
  <td width=280 valign=top style='width:210.15pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:93.1pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral fluids</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Honey and lemon in warm water</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Suck hard sweets</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Elevate head when sleeping</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:79.5pt'>
  <td width=289 valign=top style='width:216.55pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:79.5pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pharmacological Measures</span></b></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral morphine sulphate solution 2.5 mg 4
  hourly</span></p>
  <p class=MsoNormal><span lang=EN-US>OR</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Codeine 15 mg 4 hourly</span></p>
  <p class=MsoNormal><span lang=EN-US>If severe or not expected to survive</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Continuous subcutaneous infusion injectable
  morphine sulphate 10 mg over 24 hours with 2.5-5 mg SC PRN 4 hourly for
  breakthrough coughing</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US>Delirium &amp; Agitation</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:119.45pt'>
  <td width=297 valign=top style='width:222.95pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:119.45pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Provide reassurance and reorientation (for
  example explaining to someone where they are and what your role is)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Ensure adequate lighting</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Avoid moving people from one ward to another
  where possible</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pharmacological Measures</span></b></p>
  <p class=MsoNormal><span lang=EN-US>Delirium ONLY requires drugs if the
  patient is posing a risk to themselves or very agitated. If they are just
  mildly confused then medications may just cause them to be more drowsy and at
  greater risk of falls.</span></p>
  <p class=MsoNormal><span lang=EN-US>First-line is haloperidol</span></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Haloperidol 1.25 mg oral PRN 2 hourly</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>If necessary increase in 1.25 mg increments up
  to 10 mg</span></p>
  <p class=MsoNormal><span lang=EN-US>Second-line as an adjunct to haloperidol</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Diazepam 2 mg oral TDS (can increase
  incrementally up to 10 mg oral TDS)</span></p>
  <p class=MsoNormal><span lang=EN-US>OR</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Midazolam 2.5-5 mg SC PRN 1-2 hourly</span></p>
  <p class=MsoNormal><span lang=EN-US>Not expected to survive</span></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>2.5-5 mg SC/IV stat then 1 hourly PRN</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Increase progressively to 10 mg SC/IV 1 hourly
  PRN</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Maintain with 10-60 mg/24 hours in
  subcutaneous continuous infusion</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US>Fever</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:67.05pt'>
  <td width=245 valign=top style='width:183.9pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:67.05pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Encourage loose clothing</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral fluids</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Cool cloth for face</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:108.55pt'>
  <td width=306 valign=top style='width:229.7pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:108.55pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pharmacological Measures</span></b></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Paracetamol 1 g IV/oral/PR up to QDS (but to
  maximum of 3 g per day if expected to survive)</span></p>
  <p class=MsoNormal><span lang=EN-US>NSAIDS not currently recommended in
  COVID-19, but at end of life could consider Ibuprofen 400 mg TDS</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3>Pain</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Commencing strong opioids</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral morphine sulphate solution (immediate
  release) and morphine sulphate tablets 15 mg (modified release) are available</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Always prescribe regular laxatives and
  anti-emetics when starting morphine</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Modified release tablets are BD and a PRN dose
  of immediate acting morphine should always be prescribed for breakthrough
  pain</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>PRN doses for breakthrough pain should be 1/10
  to 1/6 of the total daily dose of morphine prescribed</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>e.g. Morphine sulphate tablets 7.5 mg BD would
  require oral morphine sulphate solution 1.5 mg PRN as a breakthrough dose</span></p>
  <p class=MsoNormal><span lang=EN-US>Conversion table for opioids</span></p>
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
   style='border-collapse:collapse;border:none'>
   <tr>
    <td width=104 valign=top style='width:77.75pt;border:solid windowtext 1.0pt;
    padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
    </td>
    <td width=147 valign=top style='width:110.5pt;border:solid windowtext 1.0pt;
    border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><i><span lang=EN-US>Equivalence to oral morphine 30 mg:</span></i></p>
    </td>
   </tr>
   <tr>
    <td width=104 valign=top style='width:77.75pt;border:solid windowtext 1.0pt;
    border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><span lang=EN-US>Codeine</span></p>
    </td>
    <td width=147 valign=top style='width:110.5pt;border-top:none;border-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
    padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><span lang=EN-US>200 mg</span></p>
    </td>
   </tr>
   <tr>
    <td width=104 valign=top style='width:77.75pt;border:solid windowtext 1.0pt;
    border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><span lang=EN-US>SC morphine</span></p>
    </td>
    <td width=147 valign=top style='width:110.5pt;border-top:none;border-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
    padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=MsoNormal><span lang=EN-US>15 mg</span></p>
    </td>
   </tr>
  </table>
  <p class=MsoNormal></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Patient on no analgesia – mild pain</span></b></p>
  <p class=MsoNormal><i><span lang=EN-US>Step 1</span></i></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Regular paracetamol 1g up to QDS (↓ dose in
  elderly/↓ eGFR &amp; weight &lt; 50 kg and max 3 g/day if expected to survive)
  </span></p>
  <p class=MsoNormal><i><span lang=EN-US>Step 2</span></i></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Regular paracetamol and add codeine 30-60 mg
  oral QDS</span></p>
  <p class=MsoNormal><i><span lang=EN-US>Step 3</span></i></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span style='font-family:
  Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Stop codeine, continue paracetamol and
  commence strong opioid</span></p>
  </td>
 </tr>
</table>

<h3><span style='text-decoration:none'>&nbsp;</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Suggested starting doses of strong
  opioids</span></b></p>
  <p class=MsoNormal><span lang=EN-US>Opioid naïve/frail/elderly</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Oral morphine sulphate solution or SC morphine
  2.5-5 mg 4 hourly</span></p>
  <p class=MsoNormal><span lang=EN-US>Previously using codeine regularly</span></p>
  <p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Morphine sulphate tablets 15-30&nbsp;mg BD
  (7.5-15 mg BD if frail/elderly)</span></p>
  <p class=MsoNormal><span lang=EN-US>Morphine is metabolized in the liver and
  excreted renally so patients with liver/renal impairment need lower doses
  which are cautiously titrated up</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Titrating opioid doses</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Calculate total daily dose of long acting and
  immediate release morphine prescribed</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>If adequate pain control, take the total daily
  dose and divide by 2 to get the BD dose of modified release morphine</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>e.g. A patient prescribed MST 15&nbsp;mg BD
  also had 2 doses of 2.5&nbsp;mg morphine SC during the day. Their total daily
  requirement was 30 mg oral plus 5 mg SC (which is equivalent to 10 mg oral)
  so total oral dose was 40 mg. MST tablet sizes are 15 mg and can be quartered
  so the most appropriate dose for this patient would be 22.5&nbsp;mg BD</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<b><u><span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></u></b>

<h3>Nausea</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Non-pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Sip clear fluids</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Smaller more frequent meals with bland food</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Pharmacological Measures</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Metoclopramide 10 mg oral TDS</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Promethazine 25 mg oral/IV/deep IM TDS</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Haloperidol 1.25 mg oral BD (increased to
  maximum 10 mg/day in divided doses orally or 10 mg over 24 hours SC
  continuous infusion with syringe driver)</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-US>Also </span>see Appendix 1 for a one page
overview of pharmacological management.</p>

<h3><span style='text-decoration:none'>&nbsp;</span></h3>

<h3>Fluids and Nutrition at the End of Life</h3>

<p class=MsoNormal>There is no clear evidence that fluids and nutrition improves
someone’s quality of life or prolongs it when they are in their last days.
Often appetite is much decreased. Comfort feeds or sips of oral fluids can be
offered to those who are awake and able to swallow. Patients unable to swallow
may benefit from regular mouthcare so their mouth does not dry out. Other
patients may require SC fluids and NG tube feeds if that is decided to be the
best course of action for the patient. </p>

<h3>Patient-Centred Care</h3>

<p class=MsoNormal>As someone nears the end of life, there are many things you
can do to promote their dignity. Care must be centred around the patient with
their wishes respected. Physical needs must be cared for gently and with
respect and there may be interventions which are no longer required.
Observations can be stopped and any regular medications not providing
symptomatic relief should also be stopped. </p>

<h3>Paediatric Considerations</h3>

<p class=MsoNormal>Paediatric palliative care is a specialist area but
essentially, the key principles of assessing the patient and reacting to their
symptoms and concerns remains at the core. There will be paediatric consultants
available to review children who are very unwell. For paediatric drug doses,
please consult the Association for Paediatric Palliative Medicine Master
Formulary 2020 available online at <span lang=EN-US><a
href="https://www.appm.org.uk/guidelines-resources/appm-master-formulary/"><span
lang=EN-GB>https://www.appm.org.uk/guidelines-resources/appm-master-formulary/</span></a></span></p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>

<h2><span lang=EN-US>Key issues for Nursing care</span></h2>

<p class=MsoNormal><span lang=EN-US>Patients nearing the end of life may be
prescribed SC continuous infusions of medications or fluids. See below diagrams
for a refresher on how this access can be secured.</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 1.5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:5.0pt'><span class=Bodytext20><span
  lang=EN-US style='font-family:"Arial","sans-serif"'>Securin</span></span><span
  lang=EN-US style='color:black'>g </span><span class=Bodytext20><span
  lang=EN-US style='font-family:"Arial","sans-serif"'>subcutaneous access;</span></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>1.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Obtain necessary supplies.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>2.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Ensure appropriate hygiene and PPE.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>3.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Explain the procedure to the patient.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  13.5pt'><span lang=EN-US style='font-family:"Microsoft Sans Serif","sans-serif";
  color:black'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='color:black'>Appropriate sites of
  placement: infraclavicular. lower abdominal wall, anterior thighs or outer
  aspect of the upper arm.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>5.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Site should be: easily accessible, free of
  lesions, away from large vessels, joints and bones, away from oedematous
  tissue that may alter medication/ fluid absorption.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>6.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Clean skin with an alcohol swab for 15 seconds
  and allow skin to dry.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>7.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Remove protective shield from needle.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>8.<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='color:black'>Using thumb and index finger to create a roll
  of tissue of approximately 2.5 cm. bunch the skin around selected insertion</span></p>
  <p class=MsoNormal style='margin-left:18.0pt'><img width=179 height=139
  src="images/COVID-19_Palliative_care_MeG-CLS-088_files/image001.jpg" align=right
  hspace=15 style='margin-left:7px;margin-right:-7px;margin-top:12px;
  margin-bottom:22px'
  alt="Description: C:\Users\fakemokwe\Downloads\media\image1.jpeg"><span
  lang=EN-US style='color:black'>site.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  13.5pt'><span lang=EN-US style='font-family:"Microsoft Sans Serif","sans-serif";
  color:black'>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='color:black'>Insert the entire
  butterfly needle (23G) or yellow Jelco (24G). bevel side up. under the skin
  at an angle of 45 degrees.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  13.5pt'><span lang=EN-US style='font-family:"Microsoft Sans Serif","sans-serif";
  color:black'>10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
  lang=EN-US style='color:black'>Jelco: remove the needle and attach a short
  line; secure your cannula in place with Micropore.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>11.<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US
  style='color:black'>Butterfly needle: secure needle in place with Micropore.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;text-justify:
  inter-ideograph;text-indent:-18.0pt;line-height:13.5pt'><span lang=EN-US
  style='font-family:"Microsoft Sans Serif","sans-serif";color:black'>12.<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US
  style='color:black'>Attach a 3ml syringe and flush the tubing with normal
  saline.</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  13.5pt'><span lang=EN-US style='font-family:"Microsoft Sans Serif","sans-serif";
  color:black'>13.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
  lang=EN-US style='color:black'>Cover the insertion site, hub and wings with a
  transparent moisture- responsive dressing.</span></p>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:12.0pt;font-family:"Calibri","sans-serif"'><img
border=0 width=222 height=207 id="Picture 30"
src="images/COVID-19_Palliative_care_MeG-CLS-088_files/image002.png"></span></p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>

<h2><span lang=EN-US>References</span></h2>

<p class=MsoNormal>Integrating palliative care and symptom relief into
responses to humanitarian emergencies and crises: a WHO guide.
https://apps.who.int/iris/handle/10665/274565 </p>

<p class=MsoNormal><span lang=EN-US><a
href="https://apmonline.org/news-events/apm-covid-19-resources-for-healthcare-professionals/">https://apmonline.org/news-events/apm-covid-19-resources-for-healthcare-professionals/</a></span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>Name: Daisy Taylor</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>Date: 29 April 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>Date: 08 May 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>08 May 2022</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>

<p class=MsoNormal><b><span lang=EN-US>Appendix 1 – One page guide to symptom
control in adult patients</span></b></p>

<p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>

<table class=MsoTableGrid border=0 cellspacing=6 cellpadding=0
 style='border:none'>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 2.25pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span lang=EN-US>Breathlessness</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='margin-left:18.0pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Opioids may reduce
  the perception of breathlessness</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>MST 5 mg BD (titrate
  up to a maximum 15 mg BD)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Oral morphine
  solution 2.5-5 mg oral PRN (1-2 mg SC if unable to swallow)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Midazolam 2.5-5 mg SC
  PRN for associated agitation or distress</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:18.0pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>In the last days of
  life </span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:40.7pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='font-size:10.0pt'>Morphine 2.5-5 mg SC  and/or midazolam
  2.5 mg SC PRN</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:40.7pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Morphine 10 mg and/or
  Midazolam 10 mg over 24 hours SC continuous infusion with syringe driver
  (titrate up to morphine 30 mg/midazolam 60 mg)</span></p>
  </td>
 </tr>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid red 1.5pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span lang=EN-US>Severe Breathlessness</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='margin-left:20.85pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Morphine 5-10 mg SC
  PRN 2 hourly (reduce dose if low eGFR)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:20.85pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Midazolam 5-10 mg SC
  PRN 1-4 hourly</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:20.85pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Morphine 10-20 mg
  and/or Midazolam 10-20 mg over 24 hours SC continuous infusion with syringe
  driver (titrate up every 8 hours to incorporate the PRN doses being required)</span></p>
  </td>
 </tr>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 2.25pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span lang=EN-US>Cough</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:20.85pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Oral morphine
  sulphate solution 2.5 mg oral 4 hourly</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:20.85pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Severe or end of life</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:43.5pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Morphine sulphate 10
  mg over 24 hours SC continuous infusion with syringe driver AND 2.5-5 mg SC
  1-2 hourly PRN</span></p>
  </td>
 </tr>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 2.25pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span lang=EN-US>Delirium</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='margin-left:20.85pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>First Line</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:43.5pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='font-size:10.0pt'>Haloperidol 1.25 mg oral STAT then 2
  hourly PRN (can use 2.5 mg in severe distress)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:43.5pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span><span
  lang=EN-US style='font-size:10.0pt'>Midazolam 2.5-5 mg SC PRN 1-2 hourly</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-left:20.85pt;text-indent:
  -18.0pt'><span lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>End of Life</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-left:43.5pt;text-indent:-18.0pt'><span
  lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Midazolam 10-60 mg
  over 24 hours SC continuous infusion with syringe driver AND 2.5-10 mg SC PRN
  1 hourly</span></p>
  </td>
 </tr>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 2.25pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-US>Fever</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Paracetamol 1 g up to
  QDS oral/IV/PR (Max 3 g in 24 hours)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>NSAIDS not currently
  recommended in COVID-19, but at end of life could consider Ibuprofen 400 mg
  TDS</span></p>
  <p class=MsoListParagraphCxSpLast><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=590 valign=top style='width:442.8pt;border:solid #0070C0 2.25pt;
  padding:4.25pt 5.4pt 4.25pt 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  lang=EN-US>Nausea</span></b></p>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Metoclopramide 10 mg
  oral TDS</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-size:10.0pt;font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US style='font-size:10.0pt'>Promethazine 25 mg
  oral/IV/deep IM TDS</span></p>
  <p class=MsoNormal style='margin-left:18.0pt'><span lang=EN-US
  style='font-size:10.0pt'>Haloperidol 1.25 mg oral BD (increased to maximum 10
  mg/day in divided doses orally or 10 mg over 24 hours SC continuous infusion
  with syringe driver)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
